ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,276Medicare Part D Prescriptions Filled, Including Refills

Rank: 9 out of 288

$400K Total Retail Price of All Prescriptions

Rank: 10 out of 288

250 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

20% of this provider’s 250 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

27% of this provider’s 250 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 4,751 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
HYDROCODONE-ACETAMINOPHEN 439 244 S3 1 3
LEVOTHYROXINE SODIUM 355 292 2 2
METFORMIN HCL 213 168 3 6
OMEPRAZOLE 176 112 4 4
GABAPENTIN 173 92 5 10
SIMVASTATIN 169 151 6 5
MORPHINE SULFATE ER 164 56 S2 7 25
LISINOPRIL 164 111 7 1
OXYCODONE HCL 157 25 S2 9 17
ATENOLOL 134 101 10 15
AMLODIPINE BESYLATE 127 108 11 7
FUROSEMIDE 123 104 12 8
ZOLPIDEM TARTRATE 105 60 13 24
CARISOPRODOL 101 0 R 14 87
METOPROLOL SUCCINATE 94 87 15 20
CITALOPRAM HBR 93 66 16 12
ESTRADIOL 88 34 R 17 73
WARFARIN SODIUM 85 83 18 11
PROAIR HFA 84 33 19 26
ALENDRONATE SODIUM 83 83 20 34
POTASSIUM CHLORIDE 82 78 21 18
HYDROCHLOROTHIAZIDE 82 68 21 9
TRAZODONE HCL 81 27 23 13
OXYCODONE HCL-ACETAMINOPHEN 78 29 S2 24 83
ALLOPURINOL 73 64 25 51
CYCLOBENZAPRINE HCL 73 46 R 25 33
METOPROLOL TARTRATE 69 51 27 15
PRAVASTATIN SODIUM 69 48 27 22
FLUOXETINE HCL 66 43 29 36
OXYCONTIN 65 12 S2 30 103
DIOVAN 63 51 31 108
GLIMEPIRIDE 62 47 32 63
SERTRALINE HCL 61 32 33 23
ADVAIR DISKUS 59 47 34 38
CARVEDILOL 59 59 34 27
ATORVASTATIN CALCIUM 58 36 36 21
MORPHINE SULFATE 54 29 S2 37 137
AMLODIPINE BESYLATE-BENAZEPRIL 50 25 38 197
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 14, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.